Todd C. Brady
2016
In 2016, Todd C. Brady earned a total compensation of $1.7M as President and Chief Executive Officer at Aldeyra Therapeutics, a 57% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $220,000 |
|---|---|
| Option Awards | $857,542 |
| Salary | $440,000 |
| Stock Awards | $171,518 |
| Total | $1,689,060 |
Brady received $857.5K in option awards, accounting for 51% of the total pay in 2016.
Brady also received $220K in non-equity incentive plan, $440K in salary and $171.5K in stock awards.
Rankings
In 2016, Todd C. Brady's compensation ranked 5,670th out of 14,075 executives tracked by ExecPay. In other words, Brady earned more than 59.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,670 out of 14,075 | 60th |
Division Manufacturing | 2,050 out of 5,489 | 63rd |
Major group Chemicals And Allied Products | 655 out of 1,895 | 65th |
Industry group Drugs | 491 out of 1,538 | 68th |
Industry Pharmaceutical Preparations | 390 out of 1,176 | 67th |
Source: SEC filing on April 24, 2017.
Brady's colleagues
We found three more compensation records of executives who worked with Todd C. Brady at Aldeyra Therapeutics in 2016.
News
Aldeyra Therapeutics CEO Todd Brady's 2023 pay jumps 29% to $3.7M
April 22, 2024
Aldeyra Therapeutics CEO Todd Brady's 2022 pay slips 17% to $2.9M
May 23, 2023
Aldeyra Therapeutics CEO Todd Brady's 2021 pay jumps 43% to $3.5M
April 25, 2022
Aldeyra Therapeutics CEO Todd Brady's 2019 pay jumps 44% to $4.1M
April 27, 2020
Aldeyra Therapeutics CEO Todd Brady's 2018 pay jumps 21% to $2.9M
April 22, 2019